Skip to main content
Funded Studies

Benjamin Reubinoff, MD, PhD

Director, at The Hadassah Human Embryonic Stem Cell Research Center, Department of Gynecology and The Goldyne Sav

Dr. Reubinoff received his MD degree from the Hebrew University - Hadassah Medical School, Jerusalem, Israel. He completed an internship and a residency in Obstetrics and Gynecology at the Hadassah University Hospital, Jerusalem. Dr. Reubinoff also holds a PhD degree in developmental biology from Monash University, Melbourne, Australia. Prof. Reubinoff is an Associate Professor of Obstetrics and Gynecology and serves as a senior staff physician at the Department of Obstetrics and Gynecology, Hadassah University Hospital. Dr. Reubinoff is also the director of the Hadassah Human Embryonic Stem Cell Research Center. The major focus of Dr. Reubinoff’s research in the last eight years has been human embryonic stem cells (hESCs). In the course of a sabbatical period in Australia, Dr. Reubinoff derived in collaboration with scientists from Monash University in Melbourne and the National University of Singapore, ES cell lines from human embryos. The group was the second in the world to derive human embryonic stem cell (hESC) lines and the first to show somatic differentiation of the hESCs in culture. The Hadassah Human Embryonic Stem Cell Research Center, which was founded and is directed by Dr. Reubinoff includes over 20 technicians, scientists, PhD and postdoc students. The team has extensive experience with culture, characterization manipulation and differentiation of hESCs in vitro and in vivo. The lab provides technical support in the area of hESCs to multiple laboratories. The major focus of the Center is the development of the technology that may eventually allow the exploitation of hESCs for regenerative medicine. Current areas of research include the derivation of new hESC lines from abnormal PGD embryos, the development of hESC lines from normal embryos that will be eligible for future clinical use, the development of hESC-derived neural and beta cells for the treatment of neurodegenerative disorders and diabetes, genetic manipulation of hESCs, characterizing the immunogenicity of hESCs and the study of aspects related to nuclear transfer and reprogramming. Dr. Reubinoff was awarded with many prizes for his work in the area of hESCs and has published multiple papers and authored multiple chapters on this topic.

Associated Grants

  • Dopaminergic Neurons Derived from Human Embryonic Stem Cells for Transplantation Therapy in Parkinson's Disease

    2006


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.